Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × INDUSTRY × Abscess × Clear all

Phase

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1896 Breast Neoplasms 1413 Carcinoma, Non-Small-Cell Lung 1170 Prostatic Neoplasms 737 Colorectal Neoplasms 676 Neoplasm Metastasis 622 Multiple Myeloma 541 Melanoma 525 Ovarian Neoplasms 453 Lung Neoplasms 441 Lymphoma, Non-Hodgkin 384 Lymphoma 371 Recurrence 369 Leukemia, Myeloid, Acute 365 Pancreatic Neoplasms 354 Carcinoma, Renal Cell 336 Carcinoma, Hepatocellular 285 Stomach Neoplasms 276 Leukemia, Lymphocytic, Chronic, B-Cell 268 Lymphoma, Follicular 253 Head and Neck Neoplasms 244 Glioblastoma 219 Leukemia 215 Small Cell Lung Carcinoma 180 Lymphoma, Large B-Cell, Diffuse 180 Squamous Cell Carcinoma of Head and Neck 179 Urinary Bladder Neoplasms 175 Carcinoma 175 Uterine Cervical Neoplasms 174 Advanced Solid Tumors 160

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01635764 2018-01-24

PIONEER (OLE)

AbbVie

Phase 3 Completed

508 enrolled 9 charts

Abscess, Acne Vulgaris, Hidradenitis Suppurativa

Data powered by HemOnc (CC BY 4.0) Colophon ⚡